Although AMPA receptors are known to be widely involved in excitatory
synaptic neurotransmission at the spinal level, very little is known a
bout their role in modulating motor activity In mammals. In curarized
decerebrate or spinalized rabbit preparations, fictive locomotion was
monitored on hindlimb nerves after either activation or blockade of AM
PA receptors. In decerebrate preparations, the administration of the a
ntagonist, NBQX (3.5 mg/kg i.p.) or the agonist, AMPA (0.5 mg/kg i.v.)
produced, in both cases, a depression of locomotor activities induced
by stimulation of cutaneous afferents (evoked locomotor activity). Th
is potent effect was transient with AMPA (recovery after 20 min) and f
ollowed by the occurrence of spontaneous locomotor sequences, while no
recovery was observed with NBQX treatment. In spinal preparations whe
re a continuous 'spontaneous' locomotor activity resulted from the pha
rmacological activation of noradrenergic descending pathways (nialamid
e-DOPA pretreatment), the same drugs injected at higher doses (5 mg/kg
NBQX i.p. and 1 mg/kg AMPA i.v.) only weakly affected the frequency o
f 'spontaneous' and evoked locomotor bursts while they exerted inhibit
ory and facilitatory effects on the burst amplitude respectively. The
results suggest that AMPA receptors are involved at spinal level: 1) i
n direct mediation of cutaneous afferent excitatory effects on the pos
terior locomotor generators (pLG); 2) in indirect mediation of a supra
spinal descending inhibition controlling, likely presynaptically, the
cutaneous afferent activation; and 3) in transmission to motoneurons o
f the output signals from the pLG. Finally, tight spinal interactions
between potent descending noradrenergic pathways and spinal AMPA neuro
transmission were disclosed. (C) Elsevier, Paris.